0
Article |

BISMUTH COMPOUNDS IN THE TREATMENT OF ACTIVE SYPHILIS:  A CLINICAL AND LABORATORY STUDY OF TWO HUNDRED AND EIGHTY-SIX CASES OF CUTANEOUS SYPHILIS

S. IRGANG, M.D.; E. R. ALEXANDER, M.D.; A. M. SALA, M.D.
Arch Derm Syphilol. 1933;28(3):320-352. doi:10.1001/archderm.1933.01460030014002.
Text Size: A A A
Published online

Within the past few years a number of bismuth preparations have been placed at our disposal. The ever increasing number and variety of compounds have confused the physician to such an extent that he is unable properly to appraise their value and to choose correctly the one that is best adapted to his particular case. Shall he use a soluble compound, an insoluble one or one containing both a soluble and an insoluble salt? Is the intramuscular route preferable to all others? How do these various compounds affect the human organism? It was with these problems in view that we undertook this investigation in an effort to clarify the situation.

We have attempted to study the effect of bismuth preparations on the (1) resolution of cutaneous lesions, (2) hepatic and renal functions, (3) blood pressure, (4) hemoglobin and red blood cells, (5) Wassermann reaction of the blood, (6) disappearance of

Topics

Sign In to Access Full Content

Don't have Access?

Register and get free email Table of Contents alerts, saved searches, PowerPoint downloads, CME quizzes, and more

Subscribe for full-text access to content from 1998 forward and a host of useful features

Activate your current subscription (AMA members and current subscribers)

Purchase Online Access to this article for 24 hours

First Page Preview

View Large
First page PDF preview

Figures

Tables

Interactive Graphics

Video

Country-Specific Mortality and Growth Failure in Infancy and Yound Children and Association With Material Stature

Use interactive graphics and maps to view and sort country-specific infant and early dhildhood mortality and growth failure data and their association with maternal

References

Correspondence

CME
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s “Cited By” API will populate this tab (http://www.crossref.org/citedby.html).
Submit a Comment

Some tools below are only available to our subscribers or users with an online account.

Sign In to Access Full Content

Related Content

Customize your page view by dragging & repositioning the boxes below.

Jobs